Drug Enforcement D-450-2013

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Status

Terminated

Classification

Class II

Report Date

May 29, 2013

Termination Date

May 8, 2014

Product Information

Product description
Levothroid (levothyroxine sodium tablets, USP), 175 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1326-01
Product quantity
32,345 Bottles
Reason for recall
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.

Location & Firm

Recalling firm
Lloyd Inc. of Iowa
Address
604 W Thomas Ave, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-450-2013
Event ID
65154
Recall initiation date
April 1, 2013
Center classification date
May 21, 2013
Code info
Lot #r: 1095922, Exp May-13; 1097735, Exp Jul-13; 1099892, Exp Oct-13.
More code info